Glaukos Corporation Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) Adverum Biotechnologies Inc...

Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...

Glaukos (NYSE:GKOS) will be posting its quarterly earnings results after the market closes on Thursday, May 7th. Analysts expect Glaukos to post earnings of ($0.34) per share for the quarter. Glaukos

LS Investment Advisors LLC acquired a new stake in Glaukos Corp (NYSE:GKOS) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to

Glaukos completed 4 separate licensing and acquisition deals in 2019 that have expanded the company’s scope far beyond just the glaucoma market. The company con

Louisiana State Employees Retirement System bought a new stake in Glaukos Corp (NYSE:GKOS) during the first quarter, according to the company in its most recent disclosure with the Securities and Exch

Nuveen Asset Management LLC boosted its position in Glaukos Corp (NYSE:GKOS) by 8.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 192,543 s

Exchange Traded Concepts LLC boosted its position in shares of Glaukos Corp (NYSE:GKOS) by 156.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The

FRESENIUS SE &/S (OTCMKTS:FSNUY) and Glaukos (NYSE:GKOS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommen

The glaucoma surgery devices market size has the potential to grow by USD 1.53 billion during 2020-2024

* Eikon search string for individual stock moves:* The Day Ahead newsletter: The Morning News Call newsletter: Wall Street’s main indexes were set to slide at the open on Wednesday, as a reco…

Alliancebernstein L.P. reduced its position in shares of Glaukos Corp (NYSE:GKOS) by 3.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SE

Norges Bank bought a new position in shares of Glaukos Corp (NYSE:GKOS) in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 652,31

The global glaucoma surgery devices market size is estimated to reach USD 2.6 billion by 2027, registering a CAGR of 6.9%, according to a new report by Grand View Research, Inc. Growing geriatric popu